Company news
Fennec Pharmaceuticals Inc. news in 2020
Fennec Pharmaceuticals Inc.'s news releases, calls and decks from 2020, newest first.
Fennec Pharmaceuticals Announces Third Quarter 2020 Financial Results and Provides Business Update
November 15, 2020
Fennec Announces Issuance of U.S. Patent for PEDMARK™
September 20, 2020
Fennec Pharmaceuticals Announces Second Quarter 2020 Financial Results and Provides Business Update
August 4, 2020
Fennec Pharmaceuticals Announces First Quarter 2020 Financial Results and Provides Business Update
May 13, 2020
Fennec Announces Exercise and Closing of Underwriters’ Option to Purchase Additional Shares
May 7, 2020
Fennec Announces Closing of Public Offering
May 4, 2020
Fennec Announces Pricing of Public Offering
April 29, 2020
Fennec Announces Proposed Public Offering of Common Shares
April 28, 2020
Fennec Pharmaceuticals Announces FDA Filing Acceptance and Priority Review of New Drug Application for PEDMARK™
April 12, 2020
Fennec Announces Issuance of U.S. Patent for Use of PEDMARK™
March 4, 2020
Fennec Pharmaceuticals Receives European Medicines Agency Validation for Marketing Authorization Application for Sodium Thiosulfate
February 27, 2020
Fennec Provides Business Update and Announces Fiscal Year 2019 Financial Results
February 13, 2020
Fennec Pharmaceuticals Completes Rolling Submission of New Drug Application (NDA) to U.S. Food and Drug Administration for PEDMARK™ and Also Submits Marketing Authorization Application (MAA) to European Medicines Agency
February 10, 2020
Decks in 2020
- Investor Presentation (January 2020)
Investor deck · 25 slides · January 2020